http://orcid.org/0000-0003-0170-2592
Figures & data
Figure 1. Selection of study sample and groupings based on inclusion criteria of subject in the population-based case-control study of women age 35–69, diagnosed with Stage I–III breast cancer between 1985–2001, and registered with the Danish Breast Cancer Group (n = 1682).
Figure 2. Immunohistochemical analysis of nuclear and cytoplasmic survivin expression. (A) IHC ×10 high cytoplasmic staining intensity, magnified to (B) IHC ×40, 60% high intensity, 40% low intensity. (C) IHC ×10 low/medium nuclear staining intensity, magnified to (D) IHC ×40, 5% medium intensity, 3% low intensity.
Table 1. Distribution of tumor and patient characteristics among breast cancer recurrence cases and controls by ER/TAM group among 1682 subjects in the population-based case-control study of women age 35–69, diagnosed with Stage I – III breast cancer between 1985 and 2001, and registered with the Danish Breast Cancer Group.
Table 2. Association between nuclear and cytoplasmic survivin and breast cancer recurrence from a population-based case-control study of 1312 women age 35–69, diagnosed with Stage I – III breast cancer between 1985 and 2001, and registered with the Danish Breast Cancer Group.
Table 3. Dose-response evaluation of the association between nuclear and cytoplasmic survivin and breast cancer recurrence from a population-based case-control study of 1312 women age 35–69, diagnosed with Stage I – III breast cancer between 1985 and 2001, and registered with the Danish Breast Cancer Group.